Publication | Closed Access

Low-Dose Sofosbuvir Is Safe and Effective in Treating Chronic Hepatitis C in Patients with Severe Renal Impairment or End-Stage Renal Disease

Severe Renal ImpairmentHepatologyHepatitis CViral HepatitisChronic Kidney DiseaseAntiviral Drug DevelopmentAntiviral TherapyHepatitisNephrologyAntiviral DrugMedicineEnd-stage Renal Disease